Birnbaum, Tissue Disposition of 2,3,7,8-Tetrachlorodibenzo- p -dioxin (TCDD) in Maternal and Developing Long-Evans Rats following Subchronic Exposure, Toxicological Sciences , Volume 57, Issue 2, October 2000, Pages 275283, Khatua B, El-Kurdi B, Singh VP
Is cardiometabolic risk improved by weight-loss drugs
Underlying Health Conditions Conditions such as diabetes, hormonal imbalances, or gastrointestinal issues can influence how well semaglutide GLP-1 works, potentially slowing or enhancing its effects
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for type 2 diabetes mellitus (T2DM) and weight management, have emerged as a promising treatment due to their anti-inflammatory and immunomodulatory properties
Understanding what to expect can help you stay on track